JP2018527287A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018527287A5 JP2018527287A5 JP2017560611A JP2017560611A JP2018527287A5 JP 2018527287 A5 JP2018527287 A5 JP 2018527287A5 JP 2017560611 A JP2017560611 A JP 2017560611A JP 2017560611 A JP2017560611 A JP 2017560611A JP 2018527287 A5 JP2018527287 A5 JP 2018527287A5
- Authority
- JP
- Japan
- Prior art keywords
- aqueous solution
- composition
- docetaxel
- composition according
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 22
- 239000007864 aqueous solution Substances 0.000 claims 19
- ZDZOTLJHXYCWBA-VCVYQWHSSA-N N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 ZDZOTLJHXYCWBA-VCVYQWHSSA-N 0.000 claims 9
- 229960003668 docetaxel Drugs 0.000 claims 9
- 102000008100 Human Serum Albumin Human genes 0.000 claims 7
- 108091006905 Human Serum Albumin Proteins 0.000 claims 7
- 239000013011 aqueous formulation Substances 0.000 claims 4
- 239000002904 solvent Substances 0.000 claims 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 3
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 238000002360 preparation method Methods 0.000 claims 2
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 claims 1
- 208000007766 Kaposi sarcoma Diseases 0.000 claims 1
- 206010033128 Ovarian cancer Diseases 0.000 claims 1
- 206010061535 Ovarian neoplasm Diseases 0.000 claims 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 1
- 206010060862 Prostate cancer Diseases 0.000 claims 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 1
- 208000005718 Stomach Neoplasms Diseases 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 238000001914 filtration Methods 0.000 claims 1
- 206010017758 gastric cancer Diseases 0.000 claims 1
- 201000010536 head and neck cancer Diseases 0.000 claims 1
- 208000014829 head and neck neoplasm Diseases 0.000 claims 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 1
- 208000002154 non-small cell lung carcinoma Diseases 0.000 claims 1
- 201000002528 pancreatic cancer Diseases 0.000 claims 1
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 201000011549 stomach cancer Diseases 0.000 claims 1
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 claims 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562162545P | 2015-05-15 | 2015-05-15 | |
| US62/162,545 | 2015-05-15 | ||
| US201562209053P | 2015-08-24 | 2015-08-24 | |
| US62/209,053 | 2015-08-24 | ||
| US201662299209P | 2016-02-24 | 2016-02-24 | |
| US62/299,209 | 2016-02-24 | ||
| PCT/US2016/032760 WO2016187147A1 (en) | 2015-05-15 | 2016-05-16 | Docetaxel and human serum albumin complexes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018527287A JP2018527287A (ja) | 2018-09-20 |
| JP2018527287A5 true JP2018527287A5 (enExample) | 2019-06-20 |
Family
ID=57320749
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017560611A Pending JP2018527287A (ja) | 2015-05-15 | 2016-05-16 | ドセタキセルおよびヒト血清アルブミンの複合体 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US10500285B2 (enExample) |
| EP (1) | EP3294286A4 (enExample) |
| JP (1) | JP2018527287A (enExample) |
| CN (2) | CN107683134B (enExample) |
| WO (1) | WO2016187147A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016187147A1 (en) | 2015-05-15 | 2016-11-24 | Fl Therapeutics Llc | Docetaxel and human serum albumin complexes |
| CN109715213B (zh) * | 2016-08-19 | 2021-10-01 | 珠海贝海生物技术有限公司 | 依鲁替尼制剂 |
| CN110062622B (zh) | 2016-10-27 | 2022-10-14 | 珠海贝海生物技术有限公司 | 多西他赛和人血清白蛋白的中性pH组合物 |
| US20200061020A1 (en) * | 2017-05-01 | 2020-02-27 | Zhuhai Beihai Biotech Co., Ltd. | Formulations and compositions of docetaxel |
| US20210023041A1 (en) * | 2018-04-11 | 2021-01-28 | Zhuhai Beihai Biotech Co., Ltd. | Formulations and compositions of docetaxel |
| CN112996531A (zh) * | 2018-10-17 | 2021-06-18 | 逊斯泰特生物科学有限责任公司 | 用于增强治疗效果的单一蛋白质包封的药剂 |
| KR20220137019A (ko) * | 2020-02-04 | 2022-10-11 | 주하이 베이하이 바이오테크 컴퍼니 리미티드 | 도세탁셀의 제형 |
| WO2022093794A1 (en) * | 2020-10-27 | 2022-05-05 | Elucida Oncology, Inc. | Methods of functionalizing nanoparticles |
| CN115400115B (zh) * | 2021-05-26 | 2025-01-14 | 石药集团中奇制药技术（石家庄）有限公司 | 多西他赛白蛋白组合物和免疫检查点抑制剂的组合及用途 |
| CN113577267B (zh) * | 2021-09-06 | 2022-04-08 | 江西北正干细胞生物科技有限公司 | Nk细胞和抗体的药物组合物及其在治疗癌症中的用途 |
| EP4483871A4 (en) * | 2022-02-25 | 2025-12-31 | Zhuhai Beihai Biotech Co Ltd | TAXOTER COMPOSITION AND PROCESS |
| EP4710939A1 (en) * | 2023-05-09 | 2026-03-18 | Jiangsu Alphamab Biopharmaceuticals Co., Ltd. | Combined therapy drug comprising anti-her2 bispecific antibody and use thereof |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58216126A (ja) * | 1982-06-11 | 1983-12-15 | Ono Pharmaceut Co Ltd | 可容化製剤 |
| US5977163A (en) * | 1996-03-12 | 1999-11-02 | Pg-Txl Company, L. P. | Water soluble paclitaxel prodrugs |
| HUP9701554D0 (en) | 1997-09-18 | 1997-11-28 | Human Oltoanyagtermeloe Gyogys | Pharmaceutical composition containing plazma proteins |
| WO2000006152A1 (en) * | 1998-07-30 | 2000-02-10 | Novopharm Biotech, Inc. | Pharmaceutically acceptable composition comprising an aqueous solution of paclitaxel and albumin |
| US8557861B2 (en) * | 2004-09-28 | 2013-10-15 | Mast Therapeutics, Inc. | Low oil emulsion compositions for delivering taxoids and other insoluble drugs |
| TW200730518A (en) | 2005-10-12 | 2007-08-16 | Sicor Inc | Crystalline forms of docetaxel and processes for their preparation |
| JP2009533330A (ja) | 2006-03-21 | 2009-09-17 | ドクター レディズ ラボラトリーズ リミテッド | ドセタキセルの多形体およびプロセス |
| US7662980B2 (en) | 2006-10-20 | 2010-02-16 | Scinopharm Singapore Pte Ltd. | Crystalline forms of docetaxel and process for preparation thereof |
| WO2008102374A1 (en) | 2007-02-20 | 2008-08-28 | Dabur Pharma Limited | Amorphous form of docetaxel |
| KR100878455B1 (ko) | 2007-04-10 | 2009-01-13 | 한미약품 주식회사 | 안정한 무수결정형 도세탁셀 및 이의 제조방법 |
| WO2009006590A2 (en) | 2007-07-04 | 2009-01-08 | Dr. Reddy's Laboratories Ltd. | Docetaxel process and polymorphs |
| CN101357126A (zh) * | 2008-08-11 | 2009-02-04 | 张文芳 | 一种稳定的紫杉烷类白蛋白脂质载药系统及其制备方法 |
| CN101361731A (zh) * | 2008-08-11 | 2009-02-11 | 张文芳 | 白蛋白稳定的多西紫杉醇冻干制剂及其在治疗肿瘤方面的应用 |
| CN101658516B (zh) * | 2008-08-26 | 2011-10-05 | 齐鲁制药有限公司 | 紫杉醇类药物组合物及其制备方法 |
| CZ303072B6 (cs) | 2009-02-13 | 2012-03-21 | Zentiva, K.S. | Polymerní konjugáty paclitaxelu a docetaxelu s pH rízeným uvolnováním kancerostatika |
| KR101149600B1 (ko) | 2009-12-31 | 2012-05-29 | 주식회사 삼양제넥스바이오 | 고순도 무수결정형 도세탁셀 제조방법 |
| WO2011097149A2 (en) * | 2010-02-03 | 2011-08-11 | Oncbiomune, L.L.C. | Taxane-and taxoid-protein compositions |
| BR112012024590A2 (pt) * | 2010-03-29 | 2016-05-31 | Abraxis Bioscience Inc | métodos de reforço da liberação de fármaco e da eficácia de agentes terapêuticos |
| US8890233B2 (en) | 2010-07-06 | 2014-11-18 | Macronix International Co., Ltd. | 3D memory array with improved SSL and BL contact layout |
| CN101926757B (zh) * | 2010-09-01 | 2013-01-02 | 北京大学 | 一种难溶性药物的液体组合物及其制备方法 |
| KR20120096200A (ko) | 2011-02-22 | 2012-08-30 | 동아제약주식회사 | 결정형 도세탁셀 및 이의 제조방법 |
| CN102688200B (zh) * | 2012-05-09 | 2014-03-26 | 广州帝奇医药技术有限公司 | 植物类抗癌靶向纳米制剂及其制备方法 |
| US9962452B2 (en) | 2013-02-04 | 2018-05-08 | Zhuhai Beihai Biotech Co., Ltd. | Soluble complexes of drug analogs and albumin |
| WO2016187147A1 (en) | 2015-05-15 | 2016-11-24 | Fl Therapeutics Llc | Docetaxel and human serum albumin complexes |
-
2016
- 2016-05-16 WO PCT/US2016/032760 patent/WO2016187147A1/en not_active Ceased
- 2016-05-16 EP EP16797113.4A patent/EP3294286A4/en not_active Withdrawn
- 2016-05-16 JP JP2017560611A patent/JP2018527287A/ja active Pending
- 2016-05-16 CN CN201680021595.6A patent/CN107683134B/zh active Active
- 2016-05-16 CN CN202110271253.2A patent/CN112807299B/zh active Active
- 2016-05-16 US US15/574,057 patent/US10500285B2/en active Active
-
2019
- 2019-10-30 US US16/669,152 patent/US10780172B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018527287A5 (enExample) | ||
| JP2018503668A5 (enExample) | ||
| JP2017533930A5 (enExample) | ||
| JP2018521135A5 (enExample) | ||
| HRP20231570T1 (hr) | Peptid za uporabu u imunoterapiji protiv nesitnostaničnog raka pluća i sitnostaničnog raka pluća | |
| MX2017006649A (es) | Derivados de triazolo-pirazinilo utiles como activadores de guanilato ciclasa soluble. | |
| JP2015078230A5 (enExample) | ||
| JP2014521688A5 (enExample) | ||
| HRP20192337T1 (hr) | Makrociklični inhibitori pd-1/pd-l1 i cd80(b7-1)/pd-l1 protein/protein interakcija | |
| AR080863A1 (es) | Derivados del acido1-amino-2-ciclopropiletilboronico, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento del cancer. | |
| JP2016510326A5 (enExample) | ||
| CN108026053A8 (zh) | 作为mIDH1抑制剂的稠合的咪唑类化合物 | |
| TN2019000204A1 (en) | Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same | |
| HUE052332T2 (hu) | Heteroaril-származék vagy gyógyászatilag elfogadható sója, eljárás annak elõállítására, és az ezeket hatóanyagént tartalmazó gyógyászati készítmény PI3 kinázokkal összefüggõ betegségek megelõzésére vagy kezelésére | |
| JP2016507575A5 (enExample) | ||
| HRP20220683T1 (hr) | Liječenje parkinsonove bolesti | |
| JP2018514522A5 (enExample) | ||
| JP2016504400A5 (enExample) | ||
| JP2017503014A5 (enExample) | ||
| AU2018269304A1 (en) | Preparation of biologically active complexes | |
| JP2017532965A5 (enExample) | ||
| JP2015107945A5 (enExample) | ||
| CN109689652A (zh) | 稠杂环类衍生物、其制备方法及其在医学上的应用 | |
| JP2016537338A5 (enExample) | ||
| WO2015193517A3 (en) | Liquid pharmaceutical composition comprising pemetrexed |